Bisphosphonates in preclinical bone oncology

► Bisphosphonates are inhibitors of osteoclast-mediated bone resorption. ► Bisphosphonates make the bone marrow a less favorable environment for tumor growth. ► Bisphosphonates interfere with tumor-associated angiogenesis. ► Bisphosphonates improve immune surveillance against tumors.